IL6R and pharynx cancer: It has been demonstrated that the expression of IL-6 and its receptor (IL-6R) in tissue specimens and cancer cell lines of pharyngeal cancer is higher than in non-malignant tissues and the stimulation with the same cytokine or the blockade of IL-6R led to attenuation or augmentation of cellular death following radiation, respectively (75).